The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China, and Japan gave a green light to ...

the UK. Join us and put your questions to our scientists at these online discussion events. These events, previously known as Lab Notes, are open to everyone. No previous knowledge of dementia or ...